References
- Alexander G. J. M., Nouri-Aria K. T., Eddleston A. L. W. F., Williams R. Contrasting relations between suppresor cell function and suppressor cell numbers in chronic liver disease. The Lancet 1983; i: 1291–1293
- Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. The Lancet 1984; ii: 374–376
- Bizzarro A., Cennamo G., Bonavolonta G., Leonardi E., Gastello G. Cell-mediated immunity in Graves' disease: evaluation by count of rosette-forming cells. Exp. Eye Res. 1982; 35: 385–389
- Haspel H. V., Onodera T., Prabhaka B. S., Horita M., Suzuki H., Nottkins A. L. Virus induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science 1983; 220: 304–306
- Jansson R., Totterman T. H., Sallstrom J., Dahlberg P. A. Thyroid-infiltrating and blood T-lymphocytes in Hashimoto's disease. Quantification of Tcell subsets in fine-needle aspirates using monoclonal antibodies. Program and abstracts of the 64th Annual Meeting of the Endocrine Society, San Francisco, 1983, (abstract 554)
- Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J. R. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. The Lancet 1982; ii: 1353–1356
- Mahieu P., Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J. clin. Endocr. Metab. 1972; 34: 1090–1092
- Mori H., Amino N., Iwatoni Y., et al. Increase of peripheral B-lymphocytes in Graves' disease. Clin. exp. Immunol. 1980; 42: 33–40
- Munro R. E., Lamki L., Row V. V., Volpé R. Cell mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J. clin. Endocr. Metab. 1973; 37: 286–292
- Reinherz E. L., Schlossman S. F. The differentiation and function of human T-lymphocytes. Cell 1980; 19: 821–827
- Sergott R. C., Felberg N. T., Savino P. J., Blizzard J. J., Schatz N. J. E-rosette formation in Graves'ophthalmopathy. Invest. Ophthal. vis. Sci. 1979; 75: 1245–1251
- Sergott R. C., Felberg N. T., Savino P. J., Blizzard J. J., Schatz N. J. Graves' ophthalmopathy — immunologic parameters related to corticosteroid therapy. Invest. Ophthal. vis. Sci. 1981; 20: 173–181
- Volpé R. The pathogenesis of Graves' disease: an overview. Clin. Endocr. Metab. 1978; 288: 1183–1187
- Waldmann T. A., Broder S. Suppressor cells in the regulation of the immune response. Progr. clin. Immunol. 1977; 3: 155–199
- Weetman A. P., Ludgate M., Mills P. V., McGregor A. M., Beck L., Lazarus J. H., Hall R. Cyclosporin improves Graves' ophthalmopathy. The Lancet 1983; 7: 486–489
- Werner S. C. Modification of the classification of the eye changes of Graves' disease. Amer. J. Ophthal. 1977; 83: 125–121
- Wiersinga W. M., Touber J. L. Thyroid function tests 1. Studies in euthyroid volonteers. Neth. J. Med. 1980a; 23: 162–170
- Wiersinga W. M., Touber J. L. Thyroid function tests 2. Studies in patients with thyroid diseasesneth. J. Med. 1980b; 23: 200–209